BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Cardiac Science Inc. (CSCX) Introduces the Next Generation of Burdick ECG Devices


12/9/2010 11:38:29 AM

BOTHELL, Wash., Dec. 9, 2010 Cardiac Science Corporation, a global leader in automated external defibrillator (AED) and diagnostic cardiac monitoring devices, today adds two electrocardiographs (ECGs) under its Burdick brand, known for its accuracy, reliability, and ease of use. The ECGs, available only in the U.S., deliver built-in, bi-directional communication so customers can connect to leading EMRs.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080306/AQTH510LOGO)

The Burdick 8500 ECG features a friendly user interface, multi-angle 7-inch widescreen, adjustable protocol settings, and color display to make reading the continuous waveform data easy. With the Burdick 8500 ECG, customers can:

  • View continuous 3-, 6-, and 12-leads of data on the color display.
  • Adjust the unique 7-inch adjustable widescreen color display for contrast and viewability.
  • Store up to 300 digital ECG records; enjoy on-screen QuickTips.
  • Reduce typing mistakes and save time by downloading patient information from your electronic medical record (EMR/HIS) system.
  • Eliminate the hassle of scanning and filing.
  • Enjoy an industry-leading, four-year warranty and service program for worry-free usage.

The Burdick 8300 offers similar performance, connectivity, reliability, and workflow in an economic package.

Both ECG devices clean the ECG waveform before it is measured and analyzed by the Glasgow Royal Infirmary (GRI) algorithm. With more than 30 years of continuous refinement, the GRI algorithm is the first and only to consider five clinically significant variables including gender, age, race, medication, and classification to interpret patient data.

Six Product Introductions in 2010

Cardiac Science introduced six new cardiac monitoring products (available only in the U.S.) in 2010. Information is available on the cardiacscience.com website.


About Cardiac Science

Cardiac Science, a wholly owned subsidiary of Opto Circuits (India) Ltd., develops, manufactures, and markets a family of advanced diagnostic and therapeutic cardiology devices and systems, including automated external defibrillators (AED), electrocardiograph devices (ECG/EKG), cardiac stress treadmill and systems, PC-based diagnostic workstations, Holter monitoring systems, hospital defibrillators, vital signs monitors, cardiac rehabilitation telemetry systems, and cardiology data management systems (informatics) that connect with hospital information (HIS), electronic medical record (EMR), and other information systems. The company sells a variety of related products and consumables and provides a portfolio of training, maintenance, and support services. Cardiac Science, the successor to the cardiac businesses that established the trusted Burdick®, HeartCentrix®, Powerheart®, and Quinton® brands, is headquartered in Bothell, Washington. With customers in almost 100 countries worldwide, the company has operations in North America, Europe, and Asia. For information, call 425.402.2000 or visit http://www.cardiacscience.com.

For updates and information on worldwide defibrillation and cardiac monitoring, find us on the Cardiac Science blog at http://www.cardiacscience.com/blog, Twitter at http://twitter.com/cardiacscience, Facebook at http://budurl.com/CSonFB, and YouTube at http://budurl.com/CSonYT.

For more information, contact (media) Christopher Gale at EVC Group, +1.646.201.5431.

About Opto Circuits (India) Ltd.

Opto Circuits (India) Ltd. (OCI) (BSE Code: 532391; NSE Symbol: OPTOCIRCUI), headquartered in Bengaluru, Karnataka, India, is a multi-national corporation in the business of design, development, manufacturing, and marketing of noninvasive healthcare equipment and invasive vascular products. The product profile includes patient monitoring systems, anesthesia, and respiratory care equipment, pulse oximeters, sensors, stents, catheters, and balloons. The company's key markets are in the U.S., Europe, and Asia. OCI was ranked as one amongst 200 "Best under a Billion" companies in Asia-Pacific by Forbes Asia in 2009 and 2008. For further details, please go to www.optoindia.com.

For more information, contact (media) media@optoindia.com | (investors) ir@optoindia.com | +91.80.2852.8088

LOGO: http://www.cardiacscience.com/images/main_logo.gif

SOURCE Cardiac Science Corporation



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES